# SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry

> **NCT03452774** · — · RECRUITING · sponsor: **Massive Bio, Inc.** · enrollment: 50000 (estimated)

## Conditions studied

- Cancer, Metastatic
- Cancer
- Cancer of Pancreas
- Cancer of Liver
- Cancer of Stomach
- Cancer Liver
- Cancer of Rectum
- Cancer of Kidney
- Cancer of Esophagus
- Cancer of Cervix
- Cancer of Colon
- Cancer of Larynx
- Cancer, Lung
- Cancer, Breast
- Cancer, Advanced
- Cancer Prostate
- Cancer of Neck
- Cancer of Skin
- Neuroendocrine Tumors
- Carcinoma
- Mismatch Repair Deficiency
- BRCA Gene Rearrangement
- Non Hodgkin Lymphoma
- Leukemia
- Non Small Cell Lung Cancer
- Cholangiocarcinoma
- Glioblastoma
- Central Nervous System Tumor
- Melanoma
- Urothelial Carcinoma
- Bladder Cancer
- Ovarian Cancer
- Endometrial Cancer
- Testicular Cancer
- Breast Cancer
- COVID
- Myelofibrosis
- Myeloproliferative Neoplasm
- Myeloproliferative Disorders
- Follicular Lymphoma
- Mantle Cell Lymphoma
- Marginal Zone Lymphoma
- Myelodysplastic Syndromes

## Interventions

- **OTHER:** Clinical Trial Matching

## Key facts

- **NCT ID:** NCT03452774
- **Lead sponsor:** Massive Bio, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2018-01-01
- **Primary completion:** 2038-12
- **Final completion:** 2040-06
- **Target enrollment:** 50000 (ESTIMATED)
- **Last updated:** 2025-10-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03452774

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03452774, "SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT03452774. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*